Results 291 to 300 of about 150,246 (305)

Neoadjuvant Chemotherapy

2011
openaire   +1 more source

Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry

Annals of Oncology, 2016
K Aogi, K Tsugawa
exaly  

Neoadjuvant Chemotherapy

2010
openaire   +1 more source

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

Annals of Oncology, 2013
M M Kim, A M Gonzalez-Angulo, Wendy A Woodward   +2 more
exaly  

A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important

American Journal of Surgery, 2005
Michele A Gadd, Kevin S Hughes, Michelle C Specht   +2 more
exaly  

Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer

American Journal of Surgery, 2010
Jason D Keune, Donna B Jeffe, Mario Schootman   +2 more
exaly  

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

Lancet, The
Ryunosuke Machida, Kenji Amagai, Takeo Bamba   +2 more
exaly  

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The
Ashwini Arunachalam, Steven M Keller, Ayman Samkari   +2 more
exaly  

Neoadjuvant chemotherapy for locally advanced cervical cancer

European Journal of Cancer, 2003
exaly  

Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer

Ca-A Cancer Journal for Clinicians
exaly